Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCAVALCANTE, Francisco Pimentel
dc.contributor.authorABDALA, Edson
dc.contributor.authorWEISSMANN, Leonardo
dc.contributor.authorFERREIRA, Carlos Eduardo dos Santos
dc.contributor.authorAMORIM, Gilberto
dc.contributor.authorOLIVEIRA, Vilmar Marques de
dc.contributor.authorGUILGEN, Gisah
dc.contributor.authorLANDEIRO, Luciana
dc.contributor.authorPINHO, Joao Renato Rebello
dc.contributor.authorJR, Alvaro Pulchinelli
dc.contributor.authorRIBEIRO, Heber
dc.contributor.authorSOUZA, Rafael
dc.contributor.authorROSA, Daniela Dornelles
dc.date.accessioned2022-08-12T17:07:45Z
dc.date.available2022-08-12T17:07:45Z
dc.date.issued2022
dc.description.abstractThe authors discuss the best practices on early breast cancer management during the COVID pandemic. PURPOSE An expert panel on breast cancer and COVID-19 disease was convened to address the impact of the COVID-19 pandemic for early breast cancer (eBC) management. METHODS To ensure that the most clinically relevant information was addressed, essential information was drawn from several of the latest national and international guidelines and another technical document. The expert panel met in five virtual closed sessions from November 2020 to May 2021 to consult on the relevant data from evidence-based results. The data gathered were discussed on an online platform. RESULTS This article reports the expert panel's highlights of these meetings' discussions. In addition, it provides practical recommendations covering topics regarding diagnosis, treatment, and management of patients with eBC in clinical settings routinely encountered by health care professionals amid the COVID-19 pandemic. CONCLUSION This article provided guidance on several topics regarding eBC management amid the COVID-19 pandemics to inform safer care practices.eng
dc.description.indexMEDLINEeng
dc.description.sponsorship[12233444555]
dc.identifier.citationJCO GLOBAL ONCOLOGY, v.8, article ID e2100357, 11p, 2022
dc.identifier.doi10.1200/GO.21.00357
dc.identifier.eissn2687-8941
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/48432
dc.language.isoeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINSeng
dc.relation.ispartofJco Global Oncology
dc.rightsopenAccesseng
dc.rights.holderCopyright LIPPINCOTT WILLIAMS & WILKINSeng
dc.subject.otherneoadjuvant chemotherapyeng
dc.subject.otherradiotherapy hypofractionationeng
dc.subject.otherrt-pcreng
dc.subject.othersars-cov-2eng
dc.subject.othernodeeng
dc.subject.othersurgeryeng
dc.subject.othercomplicationseng
dc.subject.othermulticentereng
dc.subject.othermastectomyeng
dc.subject.othermortalityeng
dc.subject.wosOncologyeng
dc.titleImpact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidenceeng
dc.typearticleeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalCAVALCANTE, Francisco Pimentel:Fortaleza Gen Hosp HGF, Fortaleza, Ceara, Brazil
hcfmusp.author.externalFERREIRA, Carlos Eduardo dos Santos:Albert Einstein Hosp, Sao Paulo, SP, Brazil; Brazilian Soc Clin Pathol Lab Med, Rio De Janeiro, RJ, Brazil
hcfmusp.author.externalAMORIM, Gilberto:Oncol DOr, Rio De Janeiro, RJ, Brazil; Brazilian Breast Canc Study Grp GBECAM, Porto Alegre, RS, Brazil
hcfmusp.author.externalOLIVEIRA, Vilmar Marques de:Brazilian Soc Mastol, Rio De Janeiro, RJ, Brazil; Santa Casa Sao Paulo Hosp, Sao Paulo, SP, Brazil; Santa Casa Sao Paulo Sch Med Sci, Sao Paulo, SP, Brazil
hcfmusp.author.externalGUILGEN, Gisah:Brazilian Breast Canc Study Grp GBECAM, Porto Alegre, RS, Brazil; Curitiba Canc & Transplant Inst, Curitiba, Parana, Brazil; Nossa Senhora Gracas Hosp, Curitiba, Parana, Brazil
hcfmusp.author.externalLANDEIRO, Luciana:Nucleo Oncol Bahia NOB Oncoclin Grp, Salvador, BA, Brazil
hcfmusp.author.externalJR, Alvaro Pulchinelli:Brazilian Soc Clin Pathol Lab Med, Rio De Janeiro, RJ, Brazil; Fleury Grp, Sao Paulo, SP, Brazil; Fed Univ Sao Paulo UNIFESP, Sch Med, Sao Paulo, SP, Brazil
hcfmusp.author.externalRIBEIRO, Heber:Brazilian Soc Oncol Surg, Rio De Janeiro, RJ, Brazil; AC Camargo Canc Ctr, Sao Paulo, SP, Brazil
hcfmusp.author.externalSOUZA, Rafael:Canc Treatment Inst ITC, Campo Grande, MS, Brazil
hcfmusp.author.externalROSA, Daniela Dornelles:Brazilian Breast Canc Study Grp GBECAM, Porto Alegre, RS, Brazil; Moinhos Vento Hosp, Porto Alegre, RS, Brazil; Fed Univ Hlth Sci Porto Alegre UFCSPA, Porto Alegre, RS, Brazil
hcfmusp.citation.scopus1
hcfmusp.contributor.author-fmusphcEDSON ABDALA
hcfmusp.contributor.author-fmusphcLEONARDO WEISSMANN
hcfmusp.contributor.author-fmusphcJOAO RENATO REBELLO PINHO
hcfmusp.description.articlenumbere2100357
hcfmusp.description.volume8
hcfmusp.origemWOS
hcfmusp.origem.pubmed35594492
hcfmusp.origem.scopus2-s2.0-85130863995
hcfmusp.origem.wosWOS:000807082700001
hcfmusp.publisher.cityPHILADELPHIAeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAguiar S, 2020, J SURG ONCOL, V122, P1293, DOI 10.1002/jso.26146eng
hcfmusp.relation.referenceAlmahariq MF, 2021, ANN SURG ONCOL, V28, P930, DOI 10.1245/s10434-020-08928-2eng
hcfmusp.relation.referenceAmerican College of Surgeons, COVID 19 GUID TRIAGeng
hcfmusp.relation.referenceAngarita FA, 2018, BREAST CANCER RES TR, V170, P373, DOI 10.1007/s10549-018-4747-5eng
hcfmusp.relation.reference[Anonymous], 2020, WHO INT GUID, V11, P1eng
hcfmusp.relation.reference[Anonymous], 2021, COMP AXILLARY LYMPHeng
hcfmusp.relation.reference[Anonymous], 2021, LOC REACT SYST REACT LOC REACT SYST REACTeng
hcfmusp.relation.reference[Anonymous], Nota tecnica-Informacoes atualizadas sobre vacinacao contra COVID-19 e Mamografiaeng
hcfmusp.relation.referenceBarron AU, 2018, JAMA SURG, V153, P1120, DOI 10.1001/jamasurg.2018.2696eng
hcfmusp.relation.referenceBartlett DL, 2020, ANN SURG ONCOL, V27, P1717, DOI 10.1245/s10434-020-08461-2eng
hcfmusp.relation.referenceBi Z, 2019, BREAST CANCER-TOKYO, V26, P373, DOI 10.1007/s12282-018-00934-3eng
hcfmusp.relation.referenceBitterman R, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008983.pub3eng
hcfmusp.relation.referenceBoughey JC, 2013, JAMA-J AM MED ASSOC, V310, P1455, DOI 10.1001/jama.2013.278932eng
hcfmusp.relation.referenceBrunt AM, 2018, INT J RADIAT ONCOL, V102, P1603, DOI 10.1016/j.ijrobp.2018.08.049eng
hcfmusp.relation.referenceBrunt AM, 2016, RADIOTHER ONCOL, V120, P114, DOI 10.1016/j.radonc.2016.02.027eng
hcfmusp.relation.referenceBrydak LB, 2001, SUPPORT CARE CANCER, V9, P65, DOI 10.1007/s005200000186eng
hcfmusp.relation.referenceCai GY, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2020.1854424eng
hcfmusp.relation.referenceCardoso F, 2019, ANN ONCOL, V30, P1194, DOI 10.1093/annonc/mdz173eng
hcfmusp.relation.referenceCaudle AS, 2016, J CLIN ONCOL, V34, P1072, DOI 10.1200/JCO.2015.64.0094eng
hcfmusp.relation.referenceCavalcante Francisco Pimentel, 2021, J Plast Reconstr Aesthet Surg, V74, P644, DOI 10.1016/j.bjps.2020.08.103eng
hcfmusp.relation.referenceCavalcante FP, 2020, BREAST CANCER RES TR, V184, P637, DOI 10.1007/s10549-020-05877-yeng
hcfmusp.relation.referenceCenters for Disease Control and Prevention, 2020, US ANT TESTS COVID 1eng
hcfmusp.relation.referenceCenters for Disease Control and Prevention, CLIN QUEST COVID 19eng
hcfmusp.relation.referenceCenters for Disease Control and Prevention, INT US GUID RISK ASSeng
hcfmusp.relation.referenceCenters for Disease Control and Prevention, UPD HEALTHC INF PREVeng
hcfmusp.relation.referenceCenters for Disease Control and Prevention, INT GUID COVID 19 ANeng
hcfmusp.relation.referenceCenters for Disease Control and Prevention, INT CLIN CONS US COVeng
hcfmusp.relation.referenceCenters for Disease Control and Prevention, SEQ PUTT PERS PROT Eeng
hcfmusp.relation.referenceCenters for Disease Control and Prevention, LOC REACT SYST REACTeng
hcfmusp.relation.referenceCheng MP, 2020, ANN INTERN MED, V173, P450, DOI 10.7326/M20-2854eng
hcfmusp.relation.referenceCoates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221eng
hcfmusp.relation.referenceCorti C, 2021, EUR J CANCER, V148, P316, DOI 10.1016/j.ejca.2021.01.046eng
hcfmusp.relation.referenceCurigliano G, 2020, BREAST, V52, P8, DOI 10.1016/j.breast.2020.04.006eng
hcfmusp.relation.referenceCzajka ML., 2020, STATPEARLSeng
hcfmusp.relation.referenceDesai A, 2021, NAT REV CLIN ONCOL, V18, P313, DOI 10.1038/s41571-021-00487-zeng
hcfmusp.relation.referenceDietz JR, 2020, BREAST CANCER RES TR, V181, P487, DOI 10.1007/s10549-020-05644-zeng
hcfmusp.relation.referenceDinnes J, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013705, 10.1002/14651858.CD013705.pub2]eng
hcfmusp.relation.referenceEdmonds CE, 2021, AM J ROENTGENOL, V217, P831, DOI 10.2214/AJR.21.25604eng
hcfmusp.relation.referenceEuropean Society for Medical Oncology, ESMO STAT VACC COVIDeng
hcfmusp.relation.referenceEuropean Society for Medical Oncology, ESMO MAN TREATM AD Reng
hcfmusp.relation.referenceFerreira CE, 2021, INT J INFECT DIS, V103, P260, DOI 10.1016/j.ijid.2020.11.173eng
hcfmusp.relation.referenceFinley C, 2020, CAN J SURG, V63, pS2, DOI [10.1503/cjs.005620, 10.1503/cjs.00562]eng
hcfmusp.relation.referenceFregatti P, 2020, IN VIVO, V34, P1667, DOI 10.21873/invivo.11959eng
hcfmusp.relation.referenceGiuliano AE, 2017, JAMA-J AM MED ASSOC, V318, P918, DOI 10.1001/jama.2017.11470eng
hcfmusp.relation.referenceGoshen-Lago T, 2021, JAMA ONCOL, V7, P1507, DOI 10.1001/jamaoncol.2021.2675eng
hcfmusp.relation.referenceGrimm L, SBI RECOMMENDATIONSeng
hcfmusp.relation.referenceHammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529eng
hcfmusp.relation.referenceHan HJ, 2021, INT IMMUNOPHARMACOL, V90, DOI 10.1016/j.intimp.2020.107247eng
hcfmusp.relation.referenceHaviland JS, 2013, LANCET ONCOL, V14, P1086, DOI 10.1016/S1470-2045(13)70386-3eng
hcfmusp.relation.referenceHoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052eng
hcfmusp.relation.referenceHwang ES, 2020, ANN SURG ONCOL, V27, P2600, DOI 10.1245/s10434-020-08673-6eng
hcfmusp.relation.referenceJatoi A, 2010, LUNG CANCER, V68, P234, DOI 10.1016/j.lungcan.2009.06.020eng
hcfmusp.relation.referenceKantor O, 2021, ANN SURG ONCOL, V28, P1358, DOI 10.1245/s10434-020-09073-6eng
hcfmusp.relation.referenceKantor O, 2017, BREAST J, V23, P554, DOI 10.1111/tbj.12793eng
hcfmusp.relation.referenceKaufman HW, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17267eng
hcfmusp.relation.referenceKayani B, 2020, BONE JOINT J, V102B, P1136, DOI 10.1302/0301-620X.102B9.BJJ-2020-1127.R1eng
hcfmusp.relation.referenceKo G, 2021, BREAST CANCER RES TR, V188, P825, DOI 10.1007/s10549-021-06293-6eng
hcfmusp.relation.referenceKunkler IH, 2015, LANCET ONCOL, V16, P266, DOI 10.1016/S1470-2045(14)71221-5eng
hcfmusp.relation.referenceLi YF, 2020, J MED VIROL, V92, P903, DOI 10.1002/jmv.25786eng
hcfmusp.relation.referenceLoulergue P, 2011, BRIT J CANCER, V104, P1670, DOI 10.1038/bjc.2011.142eng
hcfmusp.relation.referenceMarcus A, 2014, ADV IMMUNOL, V122, P91, DOI 10.1016/B978-0-12-800267-4.00003-1eng
hcfmusp.relation.referenceMarra A, 2020, ANN ONCOL, V31, pS1206, DOI 10.1016/j.annonc.2020.08.2318eng
hcfmusp.relation.referenceMasuda N, 2017, NEW ENGL J MED, V376, P2147, DOI 10.1056/NEJMoa1612645eng
hcfmusp.relation.referenceMattioli IA, 2020, ACS SENSORS, V5, P3655, DOI 10.1021/acssensors.0c01382eng
hcfmusp.relation.referenceMills GH, 2018, ANAESTHESIA, V73, P25, DOI 10.1111/anae.14137eng
hcfmusp.relation.referenceMinisterio da Saude (Brasil), PLAN NAC OP VAC COVeng
hcfmusp.relation.referenceMinisterio da Saude Brasil, 2022, COR BRASeng
hcfmusp.relation.referenceMiraglia JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027214eng
hcfmusp.relation.referenceMonin L, 2021, LANCET ONCOL, V22, P765, DOI 10.1016/S1470-2045(21)00213-8eng
hcfmusp.relation.referenceMoo TA, 2021, ANN SURG ONCOL, V28, P6044, DOI 10.1245/s10434-021-09910-2eng
hcfmusp.relation.referenceMoo TA, 2018, ANN SURG ONCOL, V25, P1488, DOI 10.1245/s10434-018-6429-2eng
hcfmusp.relation.referenceNational Comprehensive Cancer Network, REC NCCN COVID 19 VAeng
hcfmusp.relation.referenceNational Comprehensive Cancer Network, NCCN GUID BREAST CANeng
hcfmusp.relation.referenceNational Institute for Health and Care Excellence, COVID 19 RAP GUID AReng
hcfmusp.relation.referenceNepogodiev D, 2021, ANAESTHESIA, V76, P748, DOI 10.1111/anae.15458eng
hcfmusp.relation.referenceO'Connell RL, 2018, BRIT J SURG, V105, P1778, DOI 10.1002/bjs.10959eng
hcfmusp.relation.referenceOzutemiz C, 2021, RADIOLOGY, V300, pE296, DOI 10.1148/radiol.2021210275eng
hcfmusp.relation.referencePapautsky EL, 2020, BREAST CANCER RES TR, V184, P249, DOI 10.1007/s10549-020-05828-7eng
hcfmusp.relation.referencePray IW, 2021, MMWR-MORBID MORTAL W, V69, P1642, DOI 10.15585/mmwr.mm695152a3eng
hcfmusp.relation.referencePryor A., 2020, SAGES EAES RECOMMENDeng
hcfmusp.relation.referenceRibeiro R, 2021, ANN SURG ONCOL, V28, P1289, DOI 10.1245/s10434-020-09098-xeng
hcfmusp.relation.referenceRobinson KA, 2021, JAMA ONCOL, V7, P1395, DOI 10.1001/jamaoncol.2021.3127eng
hcfmusp.relation.referenceSeely JM, 2021, CAN ASSOC RADIOL J, V72, P601, DOI 10.1177/0846537121998949eng
hcfmusp.relation.referenceSethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259eng
hcfmusp.relation.referenceSheng JY, 2020, JCO ONCOL PRACT, V16, P665, DOI 10.1200/OP.20.00364eng
hcfmusp.relation.referenceSiegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI [10.3322/caac.21551, 10.3322/caac.21654]eng
hcfmusp.relation.referenceSimon SD, 2019, BREAST, V44, P113, DOI 10.1016/j.breast.2019.01.008eng
hcfmusp.relation.referenceSpolverato G, 2020, SURGERY, V168, P4, DOI 10.1016/j.surg.2020.04.036eng
hcfmusp.relation.referenceSung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660eng
hcfmusp.relation.referenceTee SR, 2018, BRIT J SURG, V105, P1541, DOI 10.1002/bjs.10986eng
hcfmusp.relation.referenceThakkar A, 2021, NAT CANCER, V2, P392, DOI 10.1038/s43018-021-00191-yeng
hcfmusp.relation.referenceThevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2eng
hcfmusp.relation.referenceTutt ANJ, 2021, NEW ENGL J MED, V384, P2394, DOI 10.1056/NEJMoa2105215eng
hcfmusp.relation.referenceTuttle TM, 2015, ANN SURG ONCOL, V22, P3407, DOI 10.1245/s10434-015-4629-6eng
hcfmusp.relation.referenceValero MG, 2020, ANN SURG ONCOL, V27, P344, DOI 10.1245/s10434-019-07948-xeng
hcfmusp.relation.referencevon Minckwitz G, 2019, NEW ENGL J MED, V380, P617, DOI 10.1056/NEJMoa1814017eng
hcfmusp.relation.referenceWard EM, 2017, CA-CANCER J CLIN, V67, P399, DOI 10.3322/caac.21407eng
hcfmusp.relation.referenceWorld Health Organization, 2020, CELLeng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication8f2a0908-530e-4109-9a31-d275670247f7
relation.isAuthorOfPublication51a233cd-f87b-4b53-9f48-aa8ad5401ce5
relation.isAuthorOfPublication0ada2eb1-5ac2-4e40-b4e2-6af14f33268b
relation.isAuthorOfPublication.latestForDiscovery8f2a0908-530e-4109-9a31-d275670247f7
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_CAVALCANTE_Impact_of_COVID19_Disease_in_Early_Breast_Cancer_2022.PDF
Tamanho:
220 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - IMT
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - LIM/47
Carregar mais